BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 28722290)

  • 1. Development of a cardiovascular diseases risk prediction model and tools for Chinese patients with type 2 diabetes mellitus: A population-based retrospective cohort study.
    Wan EYF; Fong DYT; Fung CSC; Yu EYT; Chin WY; Chan AKC; Lam CLK
    Diabetes Obes Metab; 2018 Feb; 20(2):309-318. PubMed ID: 28722290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of new onset of end stage renal disease in Chinese patients with type 2 diabetes mellitus - a population-based retrospective cohort study.
    Wan EYF; Fong DYT; Fung CSC; Yu EYT; Chin WY; Chan AKC; Lam CLK
    BMC Nephrol; 2017 Aug; 18(1):257. PubMed ID: 28764641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and predictors for cardiovascular disease in Chinese patients with type 2 diabetes mellitus - a population-based retrospective cohort study.
    Wan EY; Fong DY; Fung CS; Lam CL
    J Diabetes Complications; 2016 Apr; 30(3):444-50. PubMed ID: 26774791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Egg consumption and cardiovascular disease according to diabetic status: The PREDIMED study.
    Díez-Espino J; Basterra-Gortari FJ; Salas-Salvadó J; Buil-Cosiales P; Corella D; Schröder H; Estruch R; Ros E; Gómez-Gracia E; Arós F; Fiol M; Lapetra J; Serra-Majem L; Pintó X; Babio N; Quiles L; Fito M; Marti A; Toledo E;
    Clin Nutr; 2017 Aug; 36(4):1015-1021. PubMed ID: 27448949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of five-year all-cause mortality in Chinese patients with type 2 diabetes mellitus - A population-based retrospective cohort study.
    Wan EYF; Fong DYT; Fung CSC; Yu EYT; Chin WY; Chan AKC; Lam CLK
    J Diabetes Complications; 2017 Jun; 31(6):939-944. PubMed ID: 28238555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction models and nomograms for 10-year risk of end-stage renal disease in Chinese type 2 diabetes mellitus patients in primary care.
    Dong W; Wan EYF; Fong DYT; Kwok RLP; Chao DVK; Tan KCB; Hui EMT; Tsui WWS; Chan KH; Fung CSC; Lam CLK
    Diabetes Obes Metab; 2021 Apr; 23(4):897-909. PubMed ID: 33319467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the waist-to-height ratio to predict cardiovascular risk in patients with diabetes: Results from the ADVANCE-ON study.
    Rådholm K; Chalmers J; Ohkuma T; Peters S; Poulter N; Hamet P; Harrap S; Woodward M
    Diabetes Obes Metab; 2018 Aug; 20(8):1903-1910. PubMed ID: 29603537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality risk remains higher in individuals with type 1 diabetes: A population-based cohort study (the Ayrshire diabetes follow-up cohort [ADOC]).
    Collier A; Connelly PJ; Hair M; Cameron L; Ghosh S; Waugh N
    Diabetes Obes Metab; 2018 Aug; 20(8):1965-1971. PubMed ID: 29687581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-apolipoprotein A-1 autoantibodies as risk biomarker for cardiovascular diseases in type 2 diabetes mellitus.
    El-Lebedy D; Rasheed E; Kafoury M; Abd-El Haleem D; Awadallah E; Ashmawy I
    J Diabetes Complications; 2016; 30(4):580-5. PubMed ID: 26965796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk association of HbA1c variability with chronic kidney disease and cardiovascular disease in type 2 diabetes: prospective analysis of the Hong Kong Diabetes Registry.
    Luk AO; Ma RC; Lau ES; Yang X; Lau WW; Yu LW; Chow FC; Chan JC; So WY
    Diabetes Metab Res Rev; 2013 Jul; 29(5):384-90. PubMed ID: 23463747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary model for cardiovascular risk prediction in people with type 2 diabetes.
    Kengne AP; Patel A; Marre M; Travert F; Lievre M; Zoungas S; Chalmers J; Colagiuri S; Grobbee DE; Hamet P; Heller S; Neal B; Woodward M;
    Eur J Cardiovasc Prev Rehabil; 2011 Jun; 18(3):393-8. PubMed ID: 21450612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between the risk of cardiovascular disease in type 2 diabetes patients and both visit-to-visit variability and time-to-effect differences in blood pressure.
    Takao T; Kimura K; Suka M; Yanagisawa H; Kikuchi M; Kawazu S; Matsuyama Y
    J Diabetes Complications; 2015 Jul; 29(5):699-706. PubMed ID: 25861721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of individual life-years gained without cardiovascular events from lipid, blood pressure, glucose, and aspirin treatment based on data of more than 500 000 patients with Type 2 diabetes mellitus.
    Berkelmans GFN; Gudbjörnsdottir S; Visseren FLJ; Wild SH; Franzen S; Chalmers J; Davis BR; Poulter NR; Spijkerman AM; Woodward M; Pressel SL; Gupta AK; van der Schouw YT; Svensson AM; van der Graaf Y; Read SH; Eliasson B; Dorresteijn JAN
    Eur Heart J; 2019 Sep; 40(34):2899-2906. PubMed ID: 30629157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study.
    Hippisley-Cox J; Coupland C; Brindle P
    BMJ; 2017 May; 357():j2099. PubMed ID: 28536104
    [No Abstract]   [Full Text] [Related]  

  • 15. The fasting serum triglyceride levels of elderly population with different progression stages of diabetes mellitus in China.
    Gao YX; Man Q; Jia S; Li Y; Li L; Zhang J
    J Diabetes Complications; 2017 Dec; 31(12):1641-1647. PubMed ID: 28993003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lifetime and 10-year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE-T1D model.
    Helmink MAG; Hageman SHJ; Eliasson B; Sattar N; Visseren FLJ; Dorresteijn JAN; Harris K; Peters SAE; Woodward M; Szentkúti P; Højlund K; Henriksen JE; Sørensen HT; Serné EH; van Sloten TT; Thomsen RW; Westerink J
    Diabetes Obes Metab; 2024 Jun; 26(6):2229-2238. PubMed ID: 38456579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification Rule for 5-year Cardiovascular Diseases Risk using decision tree in Primary Care Chinese Patients with Type 2 Diabetes Mellitus.
    Wan EYF; Fong DYT; Fung CSC; Yu EYT; Chin WY; Chan AKC; Lam CLK
    Sci Rep; 2017 Nov; 7(1):15238. PubMed ID: 29127341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of mortality and cardiovascular disease risks with diabetes and albuminuria in urban Indigenous Australians: the DRUID follow-up study.
    Barr ELM; Cunningham J; Tatipata S; Dunbar T; Kangaharan N; Guthridge S; Li SQ; Condon JR; Shaw JE; O'Dea K; Maple-Brown LJ
    Diabet Med; 2017 Jul; 34(7):946-957. PubMed ID: 28375555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global cardiovascular mortality risk in the adult Polish population: prospective assessment of the cohorts studied in multicentre national WOBASZ and WOBASZ Senior studies.
    Piotrowski W; Waśkiewicz A; Cicha-Mikołajczyk A
    Kardiol Pol; 2016; 74(3):262-73. PubMed ID: 26365939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shortened Relative Leukocyte Telomere Length Is Associated With Prevalent and Incident Cardiovascular Complications in Type 2 Diabetes: Analysis From the Hong Kong Diabetes Register.
    Cheng F; Luk AO; Tam CHT; Fan B; Wu H; Yang A; Lau ESH; Ng ACW; Lim CKP; Lee HM; Chow E; Kong AP; Keech AC; Joglekar MV; So WY; Jenkins AJ; Chan JCN; Hardikar AA; Ma RCW
    Diabetes Care; 2020 Sep; 43(9):2257-2265. PubMed ID: 32661111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.